Charles River Laboratories International, Inc. (CRL)
$301.86+0.02%Close
BUYBULL · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14.5B
- Beta
- 1.41
- P/E (TTM)
- -63.01
- Short % float
- 6.04%
- Days to cover
- 2.7
- SI change
- +29.1%
- 1W
- -2.87%
- 1M
- +8.48%
- vs SPY 1W
- -3.29%
- vs SPY 1M
- +6.42%
Industry peers
FMP comparable companies · ranked by market cap
- 2268.HKWuXi XDC Cayman Inc$106.1B$83.75
- WUXIFWuXi AppTec Co., Ltd.$80.6B$27.00
- 300759.SZPharmaron Beijing Co., Ltd.$61.8B$41.80
- 603127.SSJoinn Laboratories(China)Co.,Ltd.$38.0B$50.73
- WXIBFWuXi Biologics (Cayman) Inc.$28.0B$6.75
- MEDPSELLMedpace Holdings, Inc.$17.3BBULLQ 47$620.05+1.31%
- ICLRSELLICON Public Limited Company$12.6BRECOVERYQ 17$164.40+0.14%
- GNNSFGenscript Biotech Corporation$12.0B$5.50
- HNGZYHangzhou Tigermed Consulting Co., Ltd$6.9B$4.45
- CERTBUYCertara, Inc.$1.4BBEARQ -11$9.24+1.20%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 31
- VALUE
- 14
- GROWTH
- 43
- GARP
- 32
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-4.6%
REV YoY-
ROE-7.7%
EPS YoY-
ROA-3.2%
GROSS32
OP12
NET-6
[VALUATION]
P/E TTM-63.01
P/E FWD27.00
SECTOR PE20.54
INDUSTRY PE31.57
P/B5.21
P/FCF-
EV/EBITDA79.49
EV/EBIT-
PEG2.38
FCF YIELD-
RISK
INT COV-
D/E106.62
ALTMAN Z-
CURR RATIO1.35
ND/EBITDA-
BETA1.41
Company news
FAQ
- What is LOPJLB’s current signal on CRL?
- LOPJLB’s latest quantitative signal on Charles River Laboratories International, Inc. (CRL) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CRL in?
- Charles River Laboratories International, Inc. (CRL) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Charles River Laboratories International, Inc. (CRL) do?
- Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada…